Vijay Aggarwal, Ph.D
About Vijay Aggarwal, Ph.D
Vijay Aggarwal, Ph.D., Education and Expertise
Vijay Aggarwal, Ph.D., earned a BA in Chemistry from Case Western Reserve University, demonstrating a strong foundation in the sciences. He furthered his academic qualifications with a Ph.D. in Pharmacology/Toxicology from the Medical College of Virginia. This educational background has equipped him with in-depth knowledge and expertise in both chemistry and the fields of pharmacology and toxicology.
Chair, BSA Screening Committee
Vijay Aggarwal currently serves as the Chair of the BSA Screening Committee. In this role, he employs his extensive background in chemistry, pharmacology, and toxicology to oversee critical screening processes. His leadership in this position underlines his commitment to advancing scientific and diagnostic standards.
Vijay Aggarwal’s Role as CEO at Vaxigenix
Vijay Aggarwal held the position of CEO at Vaxigenix, a pharmaceutical company focused on developing vaccine treatments for colorectal cancer. His leadership was crucial in steering the company's research and development initiatives, emphasizing his dedication to advancing cancer treatments.
Leadership at Aureon Laboratories, Inc.
As President and CEO of Aureon Laboratories, Inc., Vijay Aggarwal led a predictive pathology company that offered advanced tissue analysis services. His role involved steering the company towards innovative diagnostic solutions, enhancing their service offerings in predictive pathology.
President of AAI Development Services, Inc.
Vijay Aggarwal served as President of AAI Development Services, Inc., a global contract research and development service company. His leadership facilitated the company's growth and expansion in providing comprehensive R&D services to the pharmaceutical and biotechnology industries.
Career at SmithKline Beecham Clinical Laboratories and Quest Diagnostics
Vijay Aggarwal's career at SmithKline Beecham Clinical Laboratories included notable positions such as Director of Business Development and Executive Vice President of Laboratories. He played a leading role in planning the integration of SmithKline Beecham Clinical Laboratories and Quest Diagnostics. Later, he served as President of Quest Diagnostic Ventures, where he managed new diagnostic technology, clinical trial testing, and direct-to-consumer laboratory services.
Board Positions Held by Vijay Aggarwal
Vijay Aggarwal holds board positions at several companies, including Accugenomics, Allergenis, Interpace Biosciences, Moleculera, Orbis Diagnostics, and Slone Partners. These roles highlight his extensive experience and trust within the industry, indicating his ongoing contribution to various innovative initiatives within the scientific and diagnostic communities.